GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » Retained Earnings

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Retained Earnings : BDT0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. The IBN SINA Pharmaceutical Industry's retained earnings for the quarter that ended in . 20 was BDT0.00 Mil.


The IBN SINA Pharmaceutical Industry Retained Earnings Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry Retained Earnings Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Retained Earnings

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Retained Earnings

The IBN SINA Pharmaceutical Industry Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Business Description

Traded in Other Exchanges
N/A
Address
Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Headlines

No Headlines